• HOME
  • PRODUCTS
    • BioSan
    • BioSera
    • CovaLab S.A.S. antibodies, kits and reagents
    • GenScript products
    • GoldenGate BioScience
    • Sarstedt, TPP and Biocentrix plastic wares
    • UDG molecular biology kits and reagents
      • Protein kits and reagents
      • Nucleic acid electrophoresis and blotting
      • Nucleic acid purification technologies
      • PCR & RT-PCR kits and reagents
      • Chemicals
      • Vectors and cloning kits
  • WEBSHOP
  • SERVICES
    • Clinical genomics services
    • Functional genomics services ►
      • Capillary sequencing and fragment analysis
      • NGS - New Generation Sequencing
      • Real Time PCR
      • Epigenetics: MEDIP; ChIP-Seq.
    • Bioinformatics ►
      • Data analysis/mining
      • Integrated database generation
    • Agrigenomics
    • Antibody related services
    • Proteomics
    • Biobanking
  • R&D PROJECTS
    • Genomic biomarker identification and companion diagnostics development
    • SCHIZO project
    • Immunoprecipitation kit development
    • Targeted ex-vivo gene therapy to treat AMD
    • Tear proteomic depletion kit development
    • Micro RNA measuring with UPL based technique
    • The Commercialisation of Transglutaminase
    • Antitest termelő sejtvonal fejlesztés
  • REFERENCES
    • Our partners
    • Publications
  • ABOUT US
    • UD-GenoMed introduction
    • Grants
    • Aims of UDG
    • Career
    • Quality Management System
    • 2018-1.1.2-KFI-2018-00172
  • CONTACT US
  • Hun
  • Eng

Immunoprecipitation control kit development

The aim of the project
 

epigen

Our aim is to develop the prototype of kits adaptable in tumour genetics. The developed kits give the opportunity of introducing the investigations of chromatin (material of chromosomes) or epigenetic measurements to everyday routine.

In the past decade the discovery of differences in the chromatin (by epigenetic methods) transformed the definition of cancer diseases. This breakthrough was due to the technological development in the field of basic research. Although epigenetic techniques have greatly simplified, they are still not capable to be introduced into daily routine as clinical diagnostics. The main reason for this is the lack of adequate standards.

We are willing to produce kits to improve the reliability and sensitivity of epigenetic measurements enabling the utilization in routine clinical diagnostics.

Members of consortium

The leader of this in-process research is - besides our company - the Clinical Genomic Centre of Biochemistry and Molecular Biology Institute of University of Debrecen.

Results

Our R&D project of medical sciences and life sciences will generate a new market segment related to clinical diagnostics: the market of tumour diagnostics based on epigenetics (kits and methodology).

Throughout the project we could patent a universal control system that is applicable on a wide scale.

Project leader

Bálint László Bálint, M.D., Ph.D.
Head of laboratory
Contact us!

 

 

 

Contacts

 

UD-GenoMed Medical Genomic Technologies Ltd.

University of Debrecen, Medical and Health Science Center

4032 Debrecen, Hungary, Nagyerdei krt. 98.
Theoretical Building Room 211.
Office (direct no.): +36-52-314-372
Phone: +36-52-411-717 (ext. 54616)
Email: info@ud-genomed.hu

Chief Executive Officer: Dr. János Kádas.

Mobile: +36-70-327-9896
Email: kadas.janos@ud-genomed.hu